13F Pro

SEC Form 4 reporting owner

Schmid John P.

Schmid John P. has filed 28 Form 4 transactions reported between December 23, 2025 and August 10, 2026, as a reporting owner of BlossomHill Therapeutics, Inc., a reporting owner of First Tracks Biotherapeutics, Inc., a reporting owner of ANAPTYSBIO, INC and a reporting owner of Design Therapeutics, Inc..

Name as filed: Schmid John P.

Open-market buys, 24 mo
$96K
1 lines
Open-market sales, 24 mo
$1.2M
3 lines
Companies
4
with Form 4 filings
Latest transaction
Aug 10, 2026
transaction date

Roles and reported holdings

  • BLSMBlossomHill Therapeutics, Inc.
    Aug 10, 2026

    Reporting owner

    Held directly6,000 sh as of Aug 10, 2026 · Form 4

    24 months: $96K bought

  • TRAXFirst Tracks Biotherapeutics, Inc.
    Apr 20, 2026 – Jun 15, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • ANABANAPTYSBIO, INC
    Dec 23, 2025 – Jun 15, 2026

    Reporting owner

    Held directly31,622 sh as of Mar 30, 2026 · Form 4

    24 months: $1.2M sold

  • DSGNDesign Therapeutics, Inc.
    Jun 9, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 28 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 10, 2026BLSMOpen-market purchaseCode P · direct6,000$96K@ $16.00Form 4
Jun 15, 2026TRAXOption exerciseCode M · direct6,030—Form 4
Jun 15, 2026ANABOption exerciseCode M · direct6,030—Form 4
Jun 9, 2026DSGNGrant or awardCode A · direct30,000—Form 4
May 12, 2026TRAXGrant or awardCode A · direct42,000—Form 4
May 12, 2026TRAXGrant or awardCode A · direct15,000—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct4,000—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct6,030—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct5,500—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct16,510—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct10,600—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct9,200—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct11,000—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct6,000—Form 4
Apr 20, 2026TRAXGrant or awardCode A · direct15,000—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct5,500—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct16,510—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct10,600—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct9,200—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct11,000—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct6,000—Form 4
Apr 20, 2026ANABDisposition to issuerCode D · direct15,000—Form 4
Mar 30, 2026ANABOpen-market saleCode S · direct522$30K@ $57.40Form 4
Mar 30, 2026ANABOpen-market saleCode S · direct7,527$427K@ $56.70Form 4
Mar 30, 2026ANABOpen-market saleCode S · direct12,596$702K@ $55.71Form 4
Jan 6, 2026ANABGrant or awardCode A · direct4,000—Form 4
Jan 6, 2026ANABGrant or awardCode A · direct5,500—Form 4
Dec 23, 2025ANABOther acquisition or dispositionCode J · indirect11,068$564K@ $51.00Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.